EU-PRODUCT_SAFETY-ART_2
EU-PRODUCT_SAFETY-ART_2
General Product Safety Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of General Product Safety Directive (2001/95/EC), 15 January 2002, amended by Reg 596/2009/EC, 18 July 2009
This list contains a non-exhaustive inventory of substances that fall within the European Union's hazardous substance definitions, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annexes XIV and XVII (Authorisation and Restriction lists). They can be considered hazardous for purposes of the General Product Safety Directive 2001/95/EC.
Last updated 15 listopada 2024. Database contains 5505 unique substances/entries.
Filter the list
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
yes |
yes |
Annex 17 Appendix 6 |
||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
yes |
yes |
Annex 17 Appendix 6 |
||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
yes |
||||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
yes |
Annex 17 Appendix 6 |
|||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
yes |
Annex 17 Appendix 6 |
|||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
Annex 17 |
||||
|
-
|
-
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
68583-16-4
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
572-48-5
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
1563-67-3
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
yes |
Annex 17 Appendix 2 |
||||
|
-
|
74195-78-1
|
yes |
Annex 17 Appendix 1 |
||||
|
show/hide
1,1,3,3-tetrabutyl-1,3-bis[(1-oxohexadecyl)oxy]distannoxane
EC / List no:
288-248-8
| CAS no:
85702-57-4
Silicic acid (H4SiO4), tetraethyl ester, reaction products with dibutylbis[(1-oxododecyl)oxy]stannane
EC / List no:
274-840-3
| CAS no:
70750-24-2
(Z,Z)-1,1,3,3-tetrabutyl-1,3-bis[(1-oxooctadec-9-enyl)oxy]distannoxane
EC / List no:
267-223-5
| CAS no:
67827-59-2
5,5-dibutyl-3,3,7,7-tetramethoxy-2,4,6,8-tetraoxa-3,7-disila-5-stannanonane
EC / List no:
302-825-4
| CAS no:
94134-56-2
Methyl (Z,Z)-8,8-dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatrideca-4,11-dien-13-oate
EC / List no:
239-594-3
| CAS no:
15546-11-9
2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate
EC / List no:
239-595-9
| CAS no:
15546-12-0
Diisooctyl 4,4'-[(dibutylstannylene)bis(oxy)]bis[4-oxoisocrotonate]
EC / List no:
246-701-7
| CAS no:
25168-21-2
Diisotridecyl 3,3'-[(dibutylstannylene)bis(thio)]dipropionate
EC / List no:
284-461-5
| CAS no:
84896-44-6
Dibutylbis(octadeca-9(Z),12(Z),15(Z)-trienoyloxy)stannane
EC / List no:
306-050-2
| CAS no:
95873-60-2
(9Z,12Z,15Z)-1,1,3,3-tetrabutyl-1,3-bis(octadeca-9,12,15-trienoyloxy)distannoxane
EC / List no:
305-141-4
| CAS no:
94349-25-4
Diisooctyl 2,2'-[(dibutylstannylene)bis(thio)]diacetate
EC / List no:
246-703-8
| CAS no:
25168-24-5
3,3'-[(dibutylstannylene)bis(thio)]bis(propane-1,2-diol)
EC / List no:
269-561-9
| CAS no:
68298-38-4
Butyl (Z,Z)-6,6-dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannahexadeca-2,9-dienoate
EC / List no:
239-596-4
| CAS no:
15546-16-4
6,6-dibutyl-4,4,8,8-tetraethoxy-3,5,7,9-tetraoxa-4,8-disila-6-stannaundecane
EC / List no:
289-337-4
| CAS no:
87735-26-0
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dibutylstannane
EC / List no:
300-344-4
| CAS no:
93925-42-9
Isopropyl (Z,Z)-9,9-dibutyl-2-methyl-4,7,11-trioxo-3,8,10-trioxa-9-stannatetradeca-5,12-dien-14-oate
EC / List no:
245-061-6
| CAS no:
22535-42-8
2-ethylhexyl 4,4-dibutyl-10-ethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
EC / List no:
234-186-1
| CAS no:
10584-98-2
Octyl (Z,Z)-6,6-dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaicosa-2,9-dienoate
EC / List no:
241-107-4
| CAS no:
17036-31-6
1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]distannoxane
EC / List no:
222-931-3
| CAS no:
3669-02-1
Isobutyl (Z,Z)-10,10-dibutyl-2-methyl-5,8,12-trioxo-4,9,11-trioxa-10-stannapentadeca-6,13-dien-15-oate
EC / List no:
261-812-0
| CAS no:
59571-08-3
(9Z,12Z)-1,1,3,3-tetrabutyl-1,3-bis(octadeca-9,12-dienoyloxy)distannoxane
EC / List no:
305-143-5
| CAS no:
94349-26-5
|
-
|
-
|
Annex 17 |
||||
|
-
|
-
|
Annex 17 |
|||||
|
-
|
63919-26-6
|
yes |
|||||
|
show/hide
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
EC / List no:
239-622-4
| CAS no:
15571-58-1
Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dioctylstannane
EC / List no:
300-346-5
| CAS no:
93925-43-0
Diisooctyl 2,2'-[(dioctylstannylene)bis(thio)]diacetate
EC / List no:
247-666-0
| CAS no:
26401-97-8
|
-
|
-
|
Annex 17 |
||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
19372-20-4
|
yes |
Annex 17 Appendix 1 |
||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
83-59-0
|
yes |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
yes |
Annex 17 Appendix 2 |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
P Parasites |
|||||